Cargando…

High flow nasal oxygen as a “second‐line” therapy for COVID‐19 patients intolerant to noninvasive ventilation. A retrospective cohort study

Detalles Bibliográficos
Autores principales: Lionello, Federico, Guarnieri, Gabriella, Arcaro, Giovanna, Vianello, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647974/
https://www.ncbi.nlm.nih.gov/pubmed/38028672
http://dx.doi.org/10.1002/hsr2.1685
_version_ 1785147533277790208
author Lionello, Federico
Guarnieri, Gabriella
Arcaro, Giovanna
Vianello, Andrea
author_facet Lionello, Federico
Guarnieri, Gabriella
Arcaro, Giovanna
Vianello, Andrea
author_sort Lionello, Federico
collection PubMed
description
format Online
Article
Text
id pubmed-10647974
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-106479742023-11-15 High flow nasal oxygen as a “second‐line” therapy for COVID‐19 patients intolerant to noninvasive ventilation. A retrospective cohort study Lionello, Federico Guarnieri, Gabriella Arcaro, Giovanna Vianello, Andrea Health Sci Rep Research Letter John Wiley and Sons Inc. 2023-11-15 /pmc/articles/PMC10647974/ /pubmed/38028672 http://dx.doi.org/10.1002/hsr2.1685 Text en © 2023 The Authors. Health Science Reports published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Letter
Lionello, Federico
Guarnieri, Gabriella
Arcaro, Giovanna
Vianello, Andrea
High flow nasal oxygen as a “second‐line” therapy for COVID‐19 patients intolerant to noninvasive ventilation. A retrospective cohort study
title High flow nasal oxygen as a “second‐line” therapy for COVID‐19 patients intolerant to noninvasive ventilation. A retrospective cohort study
title_full High flow nasal oxygen as a “second‐line” therapy for COVID‐19 patients intolerant to noninvasive ventilation. A retrospective cohort study
title_fullStr High flow nasal oxygen as a “second‐line” therapy for COVID‐19 patients intolerant to noninvasive ventilation. A retrospective cohort study
title_full_unstemmed High flow nasal oxygen as a “second‐line” therapy for COVID‐19 patients intolerant to noninvasive ventilation. A retrospective cohort study
title_short High flow nasal oxygen as a “second‐line” therapy for COVID‐19 patients intolerant to noninvasive ventilation. A retrospective cohort study
title_sort high flow nasal oxygen as a “second‐line” therapy for covid‐19 patients intolerant to noninvasive ventilation. a retrospective cohort study
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647974/
https://www.ncbi.nlm.nih.gov/pubmed/38028672
http://dx.doi.org/10.1002/hsr2.1685
work_keys_str_mv AT lionellofederico highflownasaloxygenasasecondlinetherapyforcovid19patientsintoleranttononinvasiveventilationaretrospectivecohortstudy
AT guarnierigabriella highflownasaloxygenasasecondlinetherapyforcovid19patientsintoleranttononinvasiveventilationaretrospectivecohortstudy
AT arcarogiovanna highflownasaloxygenasasecondlinetherapyforcovid19patientsintoleranttononinvasiveventilationaretrospectivecohortstudy
AT vianelloandrea highflownasaloxygenasasecondlinetherapyforcovid19patientsintoleranttononinvasiveventilationaretrospectivecohortstudy